Concepedia
Statistics
Publications
3
Citations
94
H-Index
Active since
2011
Affiliations
Novartis (China)(Current)
Obstetrics and Gynecology Hospital of Fudan University
Min Zhu is an author at Novartis (China) specializing in oncology, molecular oncology, and tumor penetration of drugs.
Publications per year
2011–2025
Clinicopathological and prognostic significance of EGFR over-expression in esophageal squamous cell carcinoma: a meta-analysis.
Weiwei Yu, Yan‐Mei Guo, Min Zhu et al. · PubMed · 2011 · 36 citations
Medicine, Oncology, Pathology +15
Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8+ T cell and evading IL-18BP in preclinical models
Yanyang Nan, Min Zhu, Qian Wang et al. · Molecular Therapy · 2025 · 34 citations · Full text
Life Sciences, Immunology, Oncology +17
A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer
Yue Wu, Min Zhu, Baihe Sun et al. · Journal of Nanobiotechnology · 2024 · 24 citations · Full text
Pharmacy, Oncology, Pharmacology +17
1–3 of 3